search
Back to results

Acupuncture or Self-Acupuncture in Managing Cancer-Related Fatigue in Women Who Have Received Chemotherapy for Stage I, Stage II, or Stage IIIA Breast Cancer

Primary Purpose

Anxiety Disorder, Breast Cancer, Depression

Status
Completed
Phase
Phase 3
Locations
United Kingdom
Study Type
Interventional
Intervention
acupuncture therapy
standard follow-up care
Sponsored by
University of Manchester
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Anxiety Disorder focused on measuring anxiety disorder, depression, fatigue, stage IA breast cancer, stage IB breast cancer, stage II breast cancer, stage IIIA breast cancer

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)FemaleDoes not accept healthy volunteers

DISEASE CHARACTERISTICS:

  • Diagnosis of breast cancer

    • Stage I, II, or IIIA disease
  • Completed prior chemotherapy for ≥ 1 month and up to 5 years

    • No needling on the ipsilateral arm of patients who have undergone axillary dissection
    • No needling on the lymphedematous limbs
  • Score of ≥ 5 on a 0-10 single-item screening fatigue scale, where 0 is no fatigue at all and 10 is extremely fatigued
  • Hormone receptor status not specified

PATIENT CHARACTERISTICS:

  • Life expectancy ≥ 6 months
  • Menopausal status not specified
  • Platelet count ≥ 50,000/mm^3
  • Hemoglobin ≥ 10 g/dL
  • Hematocrit ≥ 30%
  • Not pregnant
  • No needle phobia
  • No co-morbidity with any of the following:

    • Bleeding disorder
    • Thyroid dysfunction

PRIOR CONCURRENT THERAPY:

  • See Disease Characteristics
  • No planned concurrent chemoradiotherapy
  • No concurrent steroids
  • No concurrent epoetin alfa or transfusion for anemia
  • No other concurrent complementary therapies

Sites / Locations

  • University of Manchester

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm 5

Arm Type

Experimental

No Intervention

Experimental

No Intervention

Experimental

Arm Label

Arm I

Arm II

Arm A

Arm B

Arm C

Arm Description

Patients undergo a 20-minute acupuncture session once a week for 6 weeks. Patients also receive written information about fatigue and its possible management.

Patients receive standard care. They also receive written information about fatigue as in arm I.

Patients receive treatment as in arm I for 4 more weeks.

Patients receive standard care as in arm II for 4 more weeks.

Patients learn to self-acupuncture and do so weekly for 4 more weeks.

Outcomes

Primary Outcome Measures

General fatigue as measured by the Multidimensional Fatigue Inventory

Secondary Outcome Measures

Mental fatigue as measured by the Multidimensional Fatigue Inventory
Anxiety as measured by the Hospital Anxiety and Depression Scale
Depression as measured by the Hospital Anxiety and Depression Scale
Quality of life as measured by the FACT-G and Breast Cancer module

Full Information

First Posted
August 11, 2009
Last Updated
August 23, 2013
Sponsor
University of Manchester
search

1. Study Identification

Unique Protocol Identification Number
NCT00957112
Brief Title
Acupuncture or Self-Acupuncture in Managing Cancer-Related Fatigue in Women Who Have Received Chemotherapy for Stage I, Stage II, or Stage IIIA Breast Cancer
Official Title
The Efficacy of Acupuncture and Self-acupuncture in Managing Cancer-related Fatigue in Breast Cancer Patients: a Pragmatic Randomised Trial
Study Type
Interventional

2. Study Status

Record Verification Date
August 2009
Overall Recruitment Status
Completed
Study Start Date
October 2007 (undefined)
Primary Completion Date
October 2010 (Actual)
Study Completion Date
February 2013 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
University of Manchester

4. Oversight

5. Study Description

Brief Summary
RATIONALE: Acupuncture may help relieve fatigue caused by breast cancer. It is not yet known whether acupuncture is more effective than self-acupuncture in managing fatigue in women with breast cancer. PURPOSE: This randomized phase III trial is studying acupuncture to see how well it works compared with self-acupuncture in managing cancer-related fatigue in women who have received chemotherapy for stage I, stage II, or stage IIIA breast cancer.
Detailed Description
OBJECTIVES: Assess the efficacy of a course of acupuncture in the management of cancer-related fatigue in a homogeneous sample of women with stage I, II, or IIIA breast cancer who have completed adjuvant chemotherapy. Assess the efficacy of self-acupuncture in comparison to therapist-administered acupuncture in sustaining, in the longer term, any effects observed with a 6-week course of acupuncture in these patients. OUTLINE: This is a multicenter study. Patients are stratified according to study center and fatigue score (low vs moderate vs severe). Patients are randomized at 3:1 ratio (arm I: arm II) to 1 of 2 treatment arms. Arm I (experimental): Patients undergo a 20-minute acupuncture session once a week for 6 weeks. Patients also receive written information about fatigue and its possible management. Arm II (control): Patients undergo standard care. They also receive written information about fatigue as in arm I. After 6 weeks, patients in arm I are again randomized to 1 of 3 arms. Arm A: Patients receive treatment as in arm I for 4 more weeks. Arm B: Patients receive treatment as in arm II for 4 more weeks. Arm C: Patients learn to self-acupuncture and do so weekly for 4 more weeks. All patients complete questionnaires on fatigue, hospital anxiety and depression, quality of life, and use of complementary therapies at baseline and periodically during study. Patient's sociodemographic and treatment characteristic records are also reviewed. After completion of study therapy, patients are followed up periodically for 18 weeks.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Anxiety Disorder, Breast Cancer, Depression, Fatigue
Keywords
anxiety disorder, depression, fatigue, stage IA breast cancer, stage IB breast cancer, stage II breast cancer, stage IIIA breast cancer

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Phase 3
Masking
None (Open Label)
Allocation
Randomized
Enrollment
320 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Arm I
Arm Type
Experimental
Arm Description
Patients undergo a 20-minute acupuncture session once a week for 6 weeks. Patients also receive written information about fatigue and its possible management.
Arm Title
Arm II
Arm Type
No Intervention
Arm Description
Patients receive standard care. They also receive written information about fatigue as in arm I.
Arm Title
Arm A
Arm Type
Experimental
Arm Description
Patients receive treatment as in arm I for 4 more weeks.
Arm Title
Arm B
Arm Type
No Intervention
Arm Description
Patients receive standard care as in arm II for 4 more weeks.
Arm Title
Arm C
Arm Type
Experimental
Arm Description
Patients learn to self-acupuncture and do so weekly for 4 more weeks.
Intervention Type
Procedure
Intervention Name(s)
acupuncture therapy
Intervention Description
Patients undergo therapist-acupuncture with or without self-acupuncture
Intervention Type
Procedure
Intervention Name(s)
standard follow-up care
Intervention Description
Patients receive standard care
Primary Outcome Measure Information:
Title
General fatigue as measured by the Multidimensional Fatigue Inventory
Secondary Outcome Measure Information:
Title
Mental fatigue as measured by the Multidimensional Fatigue Inventory
Title
Anxiety as measured by the Hospital Anxiety and Depression Scale
Title
Depression as measured by the Hospital Anxiety and Depression Scale
Title
Quality of life as measured by the FACT-G and Breast Cancer module

10. Eligibility

Sex
Female
Accepts Healthy Volunteers
No
Eligibility Criteria
DISEASE CHARACTERISTICS: Diagnosis of breast cancer Stage I, II, or IIIA disease Completed prior chemotherapy for ≥ 1 month and up to 5 years No needling on the ipsilateral arm of patients who have undergone axillary dissection No needling on the lymphedematous limbs Score of ≥ 5 on a 0-10 single-item screening fatigue scale, where 0 is no fatigue at all and 10 is extremely fatigued Hormone receptor status not specified PATIENT CHARACTERISTICS: Life expectancy ≥ 6 months Menopausal status not specified Platelet count ≥ 50,000/mm^3 Hemoglobin ≥ 10 g/dL Hematocrit ≥ 30% Not pregnant No needle phobia No co-morbidity with any of the following: Bleeding disorder Thyroid dysfunction PRIOR CONCURRENT THERAPY: See Disease Characteristics No planned concurrent chemoradiotherapy No concurrent steroids No concurrent epoetin alfa or transfusion for anemia No other concurrent complementary therapies
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Alex Molassiotis, MD
Organizational Affiliation
University of Manchester
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Manchester
City
Manchester
State/Province
England
ZIP/Postal Code
M13 9PL
Country
United Kingdom

12. IPD Sharing Statement

Citations:
PubMed Identifier
23436910
Citation
Molassiotis A, Bardy J, Finnegan-John J, Mackereth P, Ryder WD, Filshie J, Ream E, Eaton D, Richardson A. A randomized, controlled trial of acupuncture self-needling as maintenance therapy for cancer-related fatigue after therapist-delivered acupuncture. Ann Oncol. 2013 Jun;24(6):1645-52. doi: 10.1093/annonc/mdt034. Epub 2013 Feb 21.
Results Reference
derived
PubMed Identifier
23109700
Citation
Molassiotis A, Bardy J, Finnegan-John J, Mackereth P, Ryder DW, Filshie J, Ream E, Richardson A. Acupuncture for cancer-related fatigue in patients with breast cancer: a pragmatic randomized controlled trial. J Clin Oncol. 2012 Dec 20;30(36):4470-6. doi: 10.1200/JCO.2012.41.6222. Epub 2012 Oct 29.
Results Reference
derived

Learn more about this trial

Acupuncture or Self-Acupuncture in Managing Cancer-Related Fatigue in Women Who Have Received Chemotherapy for Stage I, Stage II, or Stage IIIA Breast Cancer

We'll reach out to this number within 24 hrs